GCR Interactive: Pharmaceuticals - Collision of Biologics - McDermott Will & Emery

GCR Interactive: Pharmaceuticals – Collision of Biologics


With the biologics market a growing focus of development across the globe, what role does antitrust have to play in order to ensure healthy price competition between reference-priced biologics and competing biosimilars?

Hendrik Viaene speaks in this session which will focus on this role, and what lessons can and cannot be learned from generics, to help ensure low cost versions are available to all.

David Giardina, Sidley Austin

Sheng Li, NERA Economic Consulting
Elaine Johnston, Allen & Overy
Hendrik Viaene, McDermott, Will & Emery

For more information, and to register, please click here.

Dig Deeper

Paris, France / McDermott Event / October 18, 2022

European Healthcare & Life Sciences Symposium

London, United Kingdom / McDermott Event / September 29, 2022

HPE Europe 2022

MassBioHub, Cambridge, MA / McDermott Event / September 7, 2022

Life Sciences Boot Camp 2022

Get In Touch